Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAPT strategies for elective PCI in a real-world setting
NL-OMON51842Terminated
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of clopidogrel in coronary arteriosclerosis (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Net Adverse Clinical Events. Started Oct 2022; status: terminated.
02
Drugs
clopidogrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on NL-OMON51842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51842.